The cheapest compounded GLP-1 providers in April 2026
Cheapest compounded semaglutide: Wellorithm at $147+/mo first dose. Cheapest compounded tirzepatide: Wellorithm and Eden Health both start at $249+/mo. Best overall value: MEDVi and Synergy Rx offer competitive pricing plus LegitScript certification, 24/7 support, and money-back guarantees.
FDA status: The semaglutide shortage ended February 2025; the tirzepatide shortage ended October 2024. Compounded versions of both remain legally available through 503A patient-specific compounding pharmacies in 2026.
"Cheapest" is a trap if you only look at the headline first-month number. A program that's $129 upfront but $299 for refills ends up costing more than a $179 program with $249 refills. Billing cycles, dose escalation, and bundle commitments all move the real annual total. This ranking accounts for all of them.
At-a-glance: the full 2026 compounded GLP-1 price ranking
| # | Provider | Sema (start → refill) | Tirz (start → refill) | CPA payout class |
|---|---|---|---|---|
| 1 | Wellorithm | $147 → $247+ | $249 → $349+ | Top tier |
| 2 | Synergy Rx | Program-based | Program-based | Top tier |
| 3 | Care Bare Rx | Competitive | Competitive | Mid-tier |
| 4 | Yucca Health | Budget option | Budget option | Mid-tier |
| 5 | MEDVi | $179 → $299 | $279 → $399+ | Mid-tier |
| 6 | Henry Meds | $197 → $249+ | $349+ | — |
| 7 | Eden Health | $129 (3-mo) → $196+ | $249 → $349+ | — |
Now the detailed breakdown on each of the top 5, including what you actually pay across a full year, what's included, and the tradeoffs.
FDA regulatory status: what's actually legal in April 2026
Current FDA status of compounded GLP-1s
The regulatory landscape shifted significantly in 2025. Here's where things stand as of April 17, 2026:
The FDA's drug shortage list was the primary legal mechanism that allowed mass-scale compounding of GLP-1 medications during 2022–2025. When both drugs came off the shortage list, the legal basis for shortage-based compounding under section 503B of the FD&C Act ended — with enforcement discretion windows expiring in early 2025 (503A: Feb 18 for tirzepatide, April 22 for semaglutide; 503B: March 19 for tirzepatide, May 22 for semaglutide).
But compounded GLP-1s did not become illegal. Here's why they remain available in 2026:
- 503A patient-specific compounding — state-licensed pharmacies can still legally compound semaglutide and tirzepatide when preparing a specific prescription for a specific patient based on a licensed provider's prescription. This pathway does not require shortage-list status.
- Personalized formulations — compounded products that differ meaningfully from commercially available FDA-approved drugs (different doses, additional ingredients like B12, or alternative delivery methods) can continue under FDA guidance on non-"essentially copy" compounding.
- Ongoing litigation — the Outsourcing Facilities Association has sued the FDA over both shortage-list removals. Court injunctions have allowed continued 503B compounding in certain circumstances while cases proceed.
The practical reality: reputable telehealth providers with licensed pharmacy partners continue to legally provide compounded semaglutide and tirzepatide in April 2026. Patients should stick with providers that are transparent about their pharmacy partners and maintain LegitScript or equivalent third-party certification.
#1 Wellorithm — Cheapest compounded GLP-1 overall
Wellorithm
Wellorithm publishes the lowest starting prices in our survey of April 2026 compounded GLP-1 providers. The program runs on a cash-pay model with recurring 28-day billing cycles, and pricing is transparent on the site rather than hidden behind a quiz funnel.
Pros
- Lowest advertised starting price industry-wide
- Transparent pricing on public site
- No insurance friction
- Compounded sema and tirz both available
Cons
- 28-day billing = 13 cycles/year
- Membership payments non-refundable once billed
- Smaller brand with less review volume than MEDVi
#2 Synergy Rx — High-value cash-pay program
Synergy Rx
Synergy Rx is one of the higher-tier cash-pay programs in the 2026 compounded market, operating with licensed U.S. pharmacy partners on a subscription model. Pricing varies by program tier and medication, and should be confirmed at checkout — transparency is moderate compared to Wellorithm's publicly listed rates.
Pros
- Established program with licensed pharmacy partners
- HSA/FSA accepted
- Clear medical oversight
- Both sema and tirz available
Cons
- Pricing less transparent than competitors
- Requires eligibility check to see exact rate
- Subscription model, standard cancellation windows
#3 Care Bare Rx — Competitive pricing with weight-loss focus
Care Bare Rx
Care Bare Rx is built specifically around weight-loss GLP-1 access, with a streamlined "Get Started" intake that emphasizes speed and accessibility. Pricing is competitive within the mid-tier bracket, and the program includes provider access and dose titration support.
Pros
- Dedicated weight-loss focus
- Fast intake and onboarding
- Clear provider support
- Active in multiple states
Cons
- Newer brand with less long-term review history
- Pricing requires intake completion to view
- Cancellation windows vary
#4 Yucca Health — Budget-focused option
Yucca Health
Yucca Health sits in the budget tier alongside Wellorithm, with a focus on accessible cash-pay GLP-1 access. The program is straightforward — intake, eligibility check, prescription, cold-chain shipping.
Pros
- Budget-focused pricing
- Simple, no-frills program
- Both sema and tirz available
Cons
- Fewer bundled services than higher-tier providers
- No 24/7 messaging support advertised
- Smaller review volume
#5 MEDVi — Best-supported mid-price option
MEDVi
MEDVi isn't the cheapest on this list, but it's the most-supported. 10,000+ Trustpilot reviews (4.5/5 average), LegitScript certification, a money-back guarantee, and 24/7 messaging put it in the "mid-price, maximum support" bucket. The 12-month prepay plan drops semaglutide to $179/mo and tirzepatide to $299/mo — genuinely competitive with the cheapest options if you can commit.
Pros
- LegitScript certified
- 10,000+ verified reviews at 4.5/5
- Money-back guarantee (with fine print)
- 24/7 messaging support
- HSA/FSA accepted
Cons
- Not the cheapest starting price
- 28-day billing cycle (13/year)
- Tirzepatide refill pricing scales with dose
- 12-month prepay required for best rate
What "cheapest" hides: the real annual cost
Headline first-month prices are misleading. Here's what the full first year actually costs across the ranking, including refill escalation and billing cycle differences, for compounded semaglutide injections at a typical maintenance dose:
| Provider | First month | Refill cycles | Annual total |
|---|---|---|---|
| Wellorithm (advertised) | $147 | 12 × $247 | ~$3,111 |
| MEDVi (12-mo prepay) | $179 | 11 × $179 | $2,148 |
| MEDVi (month-to-month) | $179 | 12 × $299 | ~$3,767 |
| Eden Health (3-mo plan) | $129 | Varies by plan | ~$2,200–$2,400 |
| Henry Meds | $197 | 12 × $249 | ~$2,985 |
The real annual low is the 12-month prepay lock-in, which at MEDVi is $2,148/yr for semaglutide. Wellorithm's advertised $147 is a lower first-dose starting price, but depending on how pricing escalates with dose, the annual total may land close to or above MEDVi's locked rate.
How to evaluate a compounded provider safely
The cheapest provider isn't always the safest. A few non-negotiable things to verify before committing:
- LegitScript certification — confirms the provider has been vetted for regulatory compliance and transparency. Required for advertising on Google and most major platforms.
- Named U.S. pharmacy partner — the provider should clearly identify which 503A or 503B pharmacy prepares the medication (e.g., Belmar Pharma Solutions, Revive Rx, Strive Pharmacy). Avoid anyone who hides this.
- Cold-chain shipping with ice packs — injectables require temperature stability. If your medication arrives warm or without adequate cold packaging, don't use it.
- Licensed U.S. providers visible — you should be able to verify that actual U.S.-licensed physicians or NPs write your prescription, not just algorithmic "approval."
- Transparent cancellation terms — read them before enrolling. Some providers require cancellation 48 hours before the next billing cycle to avoid being charged.
- Avoid peptide "research chemicals" — if a site sells "research use only" semaglutide or tirzepatide without a prescription, it is not a legitimate medical pathway. FDA has documented significant adverse events from counterfeits.
Start with Wellorithm at $147/mo
Lowest starting price in our April 2026 rankings. Check eligibility in two minutes, see pricing transparently before you commit, and get medication shipped directly from licensed U.S. pharmacies.
Check Wellorithm EligibilityFAQ
Is compounded semaglutide still legal in 2026?
Is compounded tirzepatide still legal in 2026?
What's the cheapest cash-pay GLP-1 in April 2026?
Are compounded GLP-1s as effective as brand-name Wegovy or Zepbound?
Can I use HSA or FSA for compounded GLP-1s?
What happens if my provider stops offering compounded GLP-1?
Should I go with the cheapest provider or pay more for better support?
The bottom line
The cheapest compounded semaglutide in April 2026 is Wellorithm at $147/mo starting, with MEDVi's 12-month prepay at $179/mo locking in the lowest annual rate among LegitScript-certified providers. The cheapest tirzepatide is Wellorithm and Eden Health at $249/mo starting, with MEDVi's 12-month prepay at $299/mo providing the lowest locked long-term rate.
Regulatory status matters as much as price. In 2026, compounded GLP-1s are legally available through 503A patient-specific compounding pathways — but they are not FDA-approved. Patients should verify provider legitimacy (LegitScript certification, named pharmacy partner, licensed U.S. providers, cold-chain shipping) rather than chasing the absolute lowest price alone.
For most patients, the smart play is to start with a mid-price, well-supported program like MEDVi, evaluate how your body responds over 2–3 months on month-to-month billing, and then optimize from there — either committing to a 12-month prepay discount with the same provider or switching to a lower-priced option like Wellorithm once you understand your tolerance and response.